Yanliang Zhang

机构：Nanjing University of Chinese Medicine, Zhengzhou University, Nanjing Traditional Chinese Medicine Hospital, Zigong First People's Hospital · ORCID：0000-0002-0460-2995

发表论文 61 篇 · 总被引 376 次 · h-index 11

代表论文

• Enhanced neutralization of SARS-CoV-2 variant BA.2.86 and XBB sub-lineages by a tetravalent COVID-19 vaccine booster (2023 · Cell Host & Microbe · 被引 39)
• Neutralization of SARS-CoV-2 BQ.1.1, CH.1.1, and XBB.1.5 by breakthrough infection sera from previous and recent waves in China (2023 · Cell Discovery · 被引 37)
• Blockchain adoption and mode selection strategies for remanufacturing supply chain under cap-and-trade policy (2024 · Computers & Industrial Engineering · 被引 32)
• Robust neutralization of SARS-CoV-2 variants including JN.1 and BA.2.87.1 by trivalent XBB vaccine-induced antibodies (2024 · Signal Transduction and Targeted Therapy · 被引 26)
• Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants (2022 · Med · 被引 23)
• Immunogenicity of monkeypox virus surface proteins and cross-reactive antibody responses in vaccinated and infected individuals: implications for vaccine and therapeutic development (2025 · Infectious Diseases of Poverty · 被引 12)